GSK extended its collaboration with Zhifei to commercialize its shingles vaccine Shingrix in China until 2034.
Related Posts
Shell Pauses Construction at Major Biofuels Facility as European Market Falters
Shell will pause construction work at its biofuels facility in Rotterdam as it seeks to cut costs in pursuit of better returns for investors.
Philip Morris to Take $220 Million Loss on Sale of Inhaled-Medicine Unit
Philip Morris said it expects to record a loss on the sale of its inhaled-therapeutics unit to Molex Asia Holdings as it retools its pharmaceutical […]
Big Oil Urges Trump Not to Gut Biden’s Climate Law
Oil companies try to persuade the former president and his Republican allies not to slash provisions of the Inflation Reduction Act potentially worth billions.